CRISPR for the Revenue Cycle: What the ‘Digital Twin’ Means for RCM
By Jim Dumond – CRISPR is a gene-editing technology that enables scientists to chemically snip out and rearrange genetic sequences to alter DNA, often with the goal of eliminating hereditary diseases. The technology holds enormous implications for our ability to…
Read More